Brief: Maxcyte Signs Agreement With KSQ Therapeutics

MaxCyte

04/12/2019 07:53

Dec 4 (Reuters) - MaxCyte Inc  MXCT.L :
    * AGREEMENT WITH KSQ THERAPEUTICS
    * COMPANIES HAVE ENTERED INTO A NEW DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
    * KSQ GETS NON-EXCLUSIVE CLINICAL AND COMMERCIAL USE RIGHTS TO MAXCYTE'S CELL ENGINEERING
PLATFORM
TO DEVELOP MULTIPLE ADOPTIVE CELL THERAPIES
    * CO IS ELIGIBLE TO RECEIVE CERTAIN MILESTONE PAYMENTS IN ADDITION TO OTHER LICENSING FEES.

Source text for Eikon:  ID:nRSD5710Va 
Further company coverage:  MXCT.L 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))